ProGenis Pharmaceuticals is focused on developing next generation RNA therapeutics that are more efficient, safer and accessible to treat inherited rare and acquired diseases. ProGenis is headquartered in Perth, Australia, and led by world-renowned experts with significant experience in RNA therapeu...See more
Headquarters:
Australia
Company Type:
SME
Company size:
11-50 Employees
Year Founded:
2021 (4 years)
Address:
3 BRODIE-HALL DR; SUITE 7 & 10; BENTLEY, WESTERN AUSTRALIA 6102, AU
LOW
spending power
